• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Intellipharmaceutics International Inc/CA

+ Add to Watchlist

I:CN

2.7400 CAD 0.2300 9.16%

As of 12:36:38 ET on 01/26/2015.

Snapshot for Intellipharmaceutics International Inc/CA (I)

Open: 2.6100 Day's Range: 2.5200 - 2.7400 Volume: 6,265
Previous Close: 2.5100 52wk Range: 2.1400 - 5.7700 1-Yr Rtn: -32.84%

Stock Chart for I

No chart data available.
  • I:CN 2.7000
  • 1D
  • 1M
  • 1Y
2.5100
Interactive I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for I

Current P/E Ratio (ttm) -
Estimated P/E(11/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -0.4200
Est. EPS (USD) (11/2014) -0.1700
Est. PEG Ratio -
Market Cap (M CAD) 61.69
Shares Outstanding (M) 23.46
30 Day Average Volume 7,651
Price/Book (mrq) 9.2148
Price/Sale (ttm) 5.6257
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for I

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for I

IntelliPharmaCeutics International Inc. develops drug delivery technologies. The Company has developed a controlled release drug delivery platform to provide life cycle management or new chemical entity delivery system solutions for virtually any small molecule.

Isa OdidiChairman/CEOAmina OdidiPresident/COO
Shameze RampertabVP:Finance/CFOJohn Newell AllportVP:Legal Affairs & Licensing
More Company Profile & Key Executives for I

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil